Fate Therapeutics Inc. (FATE)
1.04
-0.08 (-7.14%)
At close: Mar 03, 2025, 1:02 PM
Fate Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -160.93M | -281.72M | -212.15M | -173.39M | -98.15M | -66.6M | -42.95M | -33.46M | -29.99M | -25.88M | -20.89M | -14.24M | -13.43M |
| Depreciation & Amortization | 18.28M | 13.76M | 5.85M | 3.09M | 2.19M | 1.2M | 971K | 881K | 687K | 496K | 571K | 590K | 672K |
| Stock-Based Compensation | 43.46M | 78.73M | 54.36M | 30.75M | 17.41M | 6.29M | 3.61M | 3.18M | 2.4M | 2.43M | 1.55M | 155K | 172K |
| Other Working Capital | 11.47M | -19.16M | 5.26M | -7.26M | 3.14M | 2.24M | -428K | 1.18M | 370K | -146K | -1.27M | n/a | n/a |
| Other Non-Cash Items | -52.26M | -24.27M | -18.1M | 111.42M | -7.79M | 19.04M | -613K | -1.61M | 8.14M | 517K | 3.09M | 220K | 95K |
| Deferred Income Tax | n/a | n/a | 5.07M | 1.68M | -478K | -335K | 5K | 171K | n/a | 3K | 26K | n/a | 121K |
| Change in Working Capital | 19.18M | -34.71M | 2.1M | -12.77M | 3.64M | 1.74M | 2.08M | 1.18M | 370K | 17K | 307K | n/a | 343K |
| Operating Cash Flow | -132.26M | -248.21M | -162.87M | -39.23M | -83.17M | -38.65M | -36.91M | -29.82M | -18.4M | -22.42M | -15.37M | -13.27M | -12.14M |
| Capital Expenditures | -6.15M | -35.57M | -50.7M | -4.93M | -7.39M | -2.3M | -1.73M | -457K | -1.5M | -882K | -244K | -709K | -2K |
| Acquisitions | n/a | -202.32M | 273.32M | 156.14M | 150.06M | n/a | n/a | 18K | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -358.81M | -404.8M | -968.16M | -277.34M | -248.86M | -55.66M | -39.97M | -19.68M | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 477.63M | 607.11M | 694.84M | 121.2M | 98.8M | 57.5M | 31.5M | 16M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 202.32M | -273.32M | -156.14M | -150.06M | 1.84M | -8.47M | 18K | n/a | n/a | 6K | n/a | 202K |
| Investing Cash Flow | 112.67M | 166.75M | -324.02M | -161.08M | -157.45M | -463K | -10.2M | -4.11M | -1.5M | -882K | -238K | -709K | 200K |
| Debt Repayment | n/a | n/a | n/a | n/a | -15M | n/a | 4.15M | -7.69M | -1.55M | 18.25M | 20.06M | -250K | 3.6M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 85K | 9.21M | 41.39M | 10.14M | 2.52M | 6.2M | 155K | 36.58M | 420K | 116K | 40.5M | 16.73M | 3.5M |
| Financial Cash Flow | 85K | 9.21M | 453.13M | 282.84M | 149.93M | 140.78M | 47.44M | 57.74M | 35.6M | 18.37M | 60.56M | 16.68M | 7.11M |
| Net Cash Flow | -19.51M | -72.25M | -33.76M | 82.53M | -90.7M | 101.67M | 343K | 23.8M | 15.71M | -4.93M | 44.95M | 2.7M | -4.84M |
| Free Cash Flow | -138.42M | -283.77M | -213.57M | -44.16M | -90.57M | -40.95M | -38.63M | -30.28M | -19.89M | -23.3M | -15.62M | -13.98M | -12.15M |